Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis

OBJECTIVE: Atezolizumab is becoming a significant therapy for non-small cell lung cancer (NSCLC), but its efficacy needs to be further improved. The aims of this study are to clarify the potency of atezolizumab-based therapy in advanced NSCLC patients with different clinical and molecular features,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Wenjie, Huo, Gengwei, Chen, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253603/
https://www.ncbi.nlm.nih.gov/pubmed/35799785
http://dx.doi.org/10.3389/fimmu.2022.909027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253603/
https://www.ncbi.nlm.nih.gov/pubmed/35799785
http://dx.doi.org/10.3389/fimmu.2022.909027

Ejemplares similares